We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGP icon
2326
Resources Connection
RGP
$145M
$2.53M ﹤0.01%
154,714
-3,807
-2% -$57.9K
LDL
2327
DELISTED
Lydall, Inc.
LDL
$2.52M ﹤0.01%
122,851
+4,631
+4% +$95.9K
DCOM icon
2328
Dime Commercial Bancshares
DCOM
$1.78B
$2.52M ﹤0.01%
75,072
+6,089
+9% +$196K
QNCX icon
2329
Quince Therapeutics
QNCX
$29.5M
$2.5M ﹤0.01%
223
+70
+46% +$422K
RCKT icon
2330
Rocket Pharmaceuticals
RCKT
$394M
$2.5M ﹤0.01%
109,947
+6,129
+6% +$102K
NGVC icon
2331
Vitamin Cottage Natural Grocers
NGVC
$654M
$2.49M ﹤0.01%
252,572
-90,150
-26% -$828K
ADVM
2332
DELISTED
Adverum Biotechnologies
ADVM
$2.48M ﹤0.01%
21,531
+416
+2% +$36.7K
SGRY icon
2333
Surgery Partners
SGRY
$2.03B
$2.48M ﹤0.01%
158,369
-15,818
-9% -$179K
TBRG
2334
DELISTED
TruBridge
TBRG
$2.48M ﹤0.01%
93,875
+8,030
+9% +$200K
FBK icon
2335
FB Financial Corp
FBK
$3.04B
$2.47M ﹤0.01%
62,450
+3,373
+6% +$129K
MBWM icon
2336
Mercantile Bank Corp
MBWM
$1.05B
$2.47M ﹤0.01%
67,813
-6,356
-9% -$223K
WT icon
2337
WisdomTree
WT
$3.22B
$2.47M ﹤0.01%
510,067
-1,690
-0.3% -$8.39K
YORW icon
2338
York Water
YORW
$514M
$2.46M ﹤0.01%
53,344
+2,858
+6% +$125K
IPHS
2339
DELISTED
Innophos Holdings, Inc.
IPHS
$2.45M ﹤0.01%
76,727
+2,817
+4% +$90.6K
RVI
2340
DELISTED
Retail Value Inc. Common Shares
RVI
$2.44M ﹤0.01%
723,651
+27,999
+4% +$93.7K
EWJ icon
2341
iShares MSCI Japan ETF
EWJ
$22.8B
$2.44M ﹤0.01%
41,190
CLW icon
2342
Clearwater Paper
CLW
$376M
$2.44M ﹤0.01%
114,117
+2,606
+2% +$52.4K
MITK icon
2343
Mitek Systems
MITK
$834M
$2.43M ﹤0.01%
318,193
-250,465
-44% -$2.11M
ATEN icon
2344
A10 Networks
ATEN
$1.95B
$2.43M ﹤0.01%
353,526
-74,200
-17% -$499K
CMRE icon
2345
Costamare
CMRE
$1.77B
$2.42M ﹤0.01%
254,510
+53,590
+27% +$428K
ROCC
2346
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$2.42M ﹤0.01%
79,690
+27,148
+52% +$723K
OLP
2347
One Liberty Properties
OLP
$527M
$2.41M ﹤0.01%
88,766
-8,072
-8% -$222K
CUTR
2348
DELISTED
Cutera, Inc.
CUTR
$2.4M ﹤0.01%
67,103
-2,354
-3% -$79.5K
CTO
2349
CTO Realty Growth
CTO
$815M
$2.4M ﹤0.01%
146,620
-40,527
-22% -$700K
BV icon
2350
BrightView Holdings
BV
$1.07B
$2.39M ﹤0.01%
141,800
-9,184
-6% -$160K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.